S. Hoyer et al., Damaged neuronal energy metabolism and behavior are improved by Ginkgo biloba extract (EGb 761), J NEURAL TR, 106(11-12), 1999, pp. 1171-1188
The standardized extract EGb 761 from the dried green leaves of Ginkgo bilo
ba is a complex mixture of ingredients with an uniquely broad spectrum of p
harmacological activities on the central nervous system e.g. in memory enha
ncing properties and in the regulation of cerebral glucose/energy metabolis
m. To test these effects on both behavioral and metabolic brain parameters,
the animal model of intracerebroventricular (icv) streptozotocin (STZ) tre
atment was used. To quantify the experimental data more precisely, animals
that were good performers were separated from poor performers by means of t
he holeboard test before icy administration of STZ. Good performers only we
re considered for the study. After a 1-week training period on the holeboar
d improvement was seen in all animals in learning, memory and cognition, an
d the improvement was maintained over the investigation period of 12 weeks
in the control group. In this group, the energy pool in the cerebral pariet
otemporal cortex was found to be large and the energy turnover high. After
triplicate icy STZ injection, working memory (WM), reference memory (RM), a
nd passive avoidance (PA) behavior fell off and continued to deteriorate th
roughout the investigation period. Otherwise there were no significant diff
erences in locomotor activity, excluding the possibility that activity per
se might have contributed to the behavioral abnormalities. These were accom
panied by a permanent deficit in cerebral energy metabolism. The ongoing de
terioration in behavior and the maintained deficit in cerebral energy metab
olism occurring after a triplicate icy STZ injection were significantly slo
wed down by EGb761. The deficits in learning, memory and cognition were par
tially compensated, and the disturbances in cerebral energy metabolism retu
rned to almost completely normal values. These findings underscore the bene
ficial effect of EGb761 that had been reported in dementia disorders.